DataMeds AI, Inc. (MEDS)

Price$1.00Cached quote
MEDSNasdaq
Loading local price history

Financial charts

Net income

Total cash / debt

CashTotal debt

Financial statements

4 annual periodsNewest to oldest
2025202420232022
Revenue$23.3M$18.1M$0$32.8M
Gross profit−$6.4M$1.8M$0$5.7M
Gross margin−27.54%9.75%—17.54%
Research & development——$375$1,400
Operating expenses$87.3M$7.9M$2.9M$9.2M
Operating income−$93.7M−$6.1M−$2.9M−$3.4M
Operating margin−401.70%−33.90%—−10.44%
EBITDA−$90.5M−$5.0M−$2.9M−$369,034
EBITDA margin−387.94%−27.75%—−1.13%
Net income−$101.3M−$6.9M−$2.9M−$2.7M
Net profit margin−433.95%−37.82%—−8.37%
Basic EPSper basic share-$71.50-$7.50-$3.00-$2.90
Diluted EPSper diluted share-$71.50-$7.50-$3.00-$2.90

Owners

Reported shareholders

Reference date Jun 30, 2026

Reported holdings Number of shares

View holders
Top 10 reported holders of MEDS
HolderShares held
Norton Brian
11.52M
Panchal Nikul
375.76K
Kalla Srinivas
293.33K
Patel Prashant
282.37K
AJJARAPU SURENDRA K
257.65K
SHANAHAN REBECCA M
244.72K
ANDERSON DONALD WILLIAM
244.72K
Syed Sajid
244.72K
PETERSON MICHAEL L
200K
Pirani Shafaat
102.08K

Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.

Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.

Community posts

It’s quiet here.

No posts about MEDS yet. Start the conversation.

Write the first post